• Coronado Biosciences Inc., of Burlington, Mass., filed a registration statement with the SEC for a public offering of 2 million shares of common stock. Oppenheimer & Co. Inc. and Roth Capital Partners are acting as joint book-running managers.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST